RDS specializes in remote patient monitoring. It designs, manufactures and markets MultiSense®, a continuous medical telemonitoring solution combining a CE-marked (Class IIa), miniaturized, high-performance wearable patch, a data platform and support services. Used in hospital and at home, clinically validated and protected by more than 20 patents, this solution helps secure hospital discharge, optimize care pathways and improve patients' quality of life. MultiSense is already deployed in over 15 hospitals in France and Germany and is listed by leading public hospital purchasing groups (RESAH, UNIHA). With headquarters and manufacturing facilities in Strasbourg, France, RDS relies on an international team and collaborates on several major European projects, including DARE (Eurostars), eCap (Horizon Europe) and 5G-OR (a Franco-German project). It has also won numerous awards. Since inception in 2020, it has raised a total of €32M, including €22M in equity and €10M in non-dilutive funding. Its €14M Series A round was led by Bpifrance's SPI fund, alongside Capital Grand Est, Critical Path Ventures and MACSF, its main shareholders. With a reusable, eco-conscious design, RDS aims to become the European leader in post-operative telemonitoring while laying the groundwork for US market entry in the next few years.